Share This Article:

Bilateral Mixed Germ Cell Tumour in an Adolescent Girl with Premature Ovarian Failure

Abstract Full-Text HTML Download Download as PDF (Size:2780KB) PP. 805-808
DOI: 10.4236/ojog.2014.413111    2,568 Downloads   3,106 Views   Citations


Germ cell tumours (GCTs) of the ovary are rare, comprising approximately 20% of all ovarian tumors with the malignant variant accounting for less than 5% of all ovarian neoplasms. Malignant mixed germ cell tumours are rarer still with dysgerminoma & yolk sac tumour being the most common components with three component variants being categorised in the rarest of rare varieties. Bilateral dysgerminomas occur in 15% of germ cell neoplasms but rarely present with premature ovarian failure. We present the case of an adolescent girl with a short history of abdominal pain and distension with amenorrhoea for a year. Clinical and radio ogical examination revealed a pelvic/adnexal mass with elevation of tumour markers and she had to undergo a staging laparotomy with bilateral salpingo-oophorectomy. Histopatholgy examination was reported as malignant mixed germ cell tumour of left ovary, predominantly with immature teratoma and minor components of yolk-sac tumour and dysgerminoma and right ovary with dysgerminoma. In view of mixed germ cell disease, she was planned for adjuvant chemotherapy.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Roy, P. , Biswas, B. , Paul, S. , Choudhrie, L. and Jose, R. (2014) Bilateral Mixed Germ Cell Tumour in an Adolescent Girl with Premature Ovarian Failure. Open Journal of Obstetrics and Gynecology, 4, 805-808. doi: 10.4236/ojog.2014.413111.


[1] Kurman, R.J. and Norris, H.J. (1977) Malignant Germ Cell Tumors of the Ovary. Human Pathology, 8, 551-564.
[2] Gershenson, D.M. (1993) Update on Malignant Ovarian Germ Cell Tumors. Cancer, 71, 1581-1590.
[3] Lim, F.K., Chanrachakul, B., Chong, S.M., et al. (1998) Malignant Ovarian Germ Cell Tumours: Experience in the National University Hospital of Singapore. Annals Academy of Medicine Singapore, 27, 657-661.
[4] De Palo, G., Pilotti, S., Kenda, R., et al. (1982) Natural History of Dysgerminoma. American Journal of Obstetrics Gynecology, 143, 799-807.
[5] Serov, S.F., Scully, R.E. and Sorbin, L.J. (1973) Histological Typing of Ovarian Tumors. In: World Health Organization International Histological Classification of Tumors, WHO, Geneva, 17-18.
[6] Krepart, G., Smith, J., Rutledge, F., et al. (1978) The Treatment for Dysgerminoma of the Ovary. Cancer, 41, 986-990.<986::AID-CNCR2820410328>3.0.CO;2-P
[7] Vriesendorp, R., Aalders, J., Sleijfer, D., et al. (1984) Treatment of Malignant Germ Cell Tumors of the Ovary with Cisplatin, Vinblastine, and Bleomycin. Cancer Treatment Reports, 68, 779-781.
[8] Thomas, G., Dembo, A., Hacker, N., et al. (1987) Current Therapy for Dysgerminoma of the Ovary. Obstetrics Gynecology, 70, 268-275.

comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.